RepliCel Life Sciences Inc.
RP
Rank in Stocks
#38679
Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a... Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.
Share Price
$0.01100905
Last synced: 2025-02-28
Market Cap
$810.02K
Change (1 day)
58.98%
Change (1 year)
10,909.05%
Country
CA
Trade RepliCel Life Sciences Inc. (RP)
Category
Healthcare
Stock split history for RepliCel Life Sciences Inc. (RP)
RepliCel Life Sciences Inc. stock (symbol: RP) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 19, 2026.
One RP share bought prior to Oct 19, 2026 would equal to 0 RP shares today.
The most recent stock split occurred on Oct 19, 2026.
One RP share bought prior to Oct 19, 2026 would equal to 0 RP shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
